Acadian Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$27K Buy
2025
Q1
Sell
2024
Q4
$230K Sell
2024
Q3
$304K Buy
2024
Q2
$167K Buy
2024
Q1
Sell
2023
Q4
$237K Buy
2023
Q3
Sell
2023
Q2
$177K Buy
2023
Q1
Sell
2022
Q4
$2.87M Sell
2022
Q3
$4.64M Buy
2022
Q2
$836K Sell
2022
Q1
$3.67M Buy
2019
Q2
Sell
2019
Q1
$333K Buy
2017
Q2
Sell
2017
Q1
$52K Buy